Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations [Phase 1]
Phase 1 study evaluating intermittent, high-dose afatinib to determine the maximal tolerated dose and assess activity in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing intercalating and maintenance use of Iressa (gefitinib) versus chemotherapy in selected advanced non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed, carboplatin, and bevacizumab as first-line therapy in older patients with stage IIIB or IV non-small ce…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer [NA]
The study evaluated radiofrequency ablation as a treatment for Stage I non-small cell lung cancer, and results from the completed trial have…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating radiation with or without brachytherapy in patients with non-s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Study of Metatinib Tromethamine Tablet [Phase 1]
This document provides a Phase 1 clinical trial update for Metatinib Tromethamine Tablet investigating advanced or metastatic gastric cancer…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating carboplatin and paclitaxel albumin-stabilized nanoparticle formulation with radiation therapy and erlotini…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of gemcitabine and docetaxel for patients with recurrent stage III or stage IV non-small…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) [Phase 2, Phase 3]
Clinical trial comparing two doses of pembrolizumab vs docetaxel in previously treated non-small cell lung cancer; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating paclitaxel/carboplatin with or without olaratumab (IMC-3G3) in previously untreated locally advanced or metastatic …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Erlotinib with or without Carboplatin and Paclitaxel in stage IIIB/IV non-small cell lung cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating sorafenib in patients with stage IIIB or stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) [Phase 2]
Phase 2 clinical trial evaluating dalotuzumab in combination with erlotinib for non-small cell lung cancer has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing surgery with or without internal radiation therapy in stage I non-small cell lung cancer has completed with results …
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR] [Phase 2]
Phase 2 trial update of atezolizumab in PD-L1 positive locally advanced or metastatic non-small cell lung cancer completed with results post…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluated a regimen of carboplatin, irinotecan, and radiation therapy followed by docetaxel in patients with newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of ABI-007 administered weekly in chemotherapy-naive patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating gemcitabine plus oxaliplatin as second-line therapy for stage III or IV non-s…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial update reports the completion of a study evaluating gefitinib alone or in combination with carboplatin and paclitaxel in …
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of temsirolimus plus pemetrexed in recurrent or refractory Non-Small Cell Lung Cancer was terminated, with results posted De…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, Abraxane, and bevacizumab in previously untreated advanced non-small cell lung cancer completed with r…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Early Palliative Care on Quality of Life of Advanced Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether early palliative care improves quality of life in advanced cancers. The study includes non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium plus gemcitabine for locally advanced or metastatic non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib [Phase 3]
Phase 3 randomized trial evaluating tivantinib (ARQ 197) plus erlotinib versus placebo plus erlotinib in non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC
A completed clinical trial investigating dynamic changes in circulating tumor cells during chemotherapy for non-small cell lung cancer. The …